Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2013 Dec 09;812:e84717. doi: 10.1371/journal.pone.0084717.
Show Gene links
Show Anatomy links
Protein tyrosine phosphatase 4A3 (PTP4A3) is required for Xenopus laevis cranial neural crest migration in vivo.
Maacha S
,
Planque N
,
Laurent C
,
Pegoraro C
,
Anezo O
,
Maczkowiak F
,
Monsoro-Burq AH
,
Saule S
.
???displayArticle.abstract???
Uveal melanoma is the most common intraocular malignancy in adults, representing between about 4% and 5% of all melanomas. High expression levels of Protein Tyrosine Phosphatase 4A3, a dual phosphatase, is highly predictive of metastasis development and PTP4A3 overexpression in uveal melanoma cells increases their in vitro migration and in vivo invasiveness. Melanocytes, including uveal melanocytes, are derived from the neural crest during embryonic development. We therefore suggested that PTP4A3 function in uveal melanoma metastasis may be related to an embryonic role during neural crest cell migration. We show that PTP4A3 plays a role in cephalic neural crest development in Xenopus laevis. PTP4A3 loss of function resulted in a reduction of neural crest territory, whilst gain of function experiments increased neural crest territory. Isochronic graft experiments demonstrated that PTP4A3-depleted neural crest explants are unable to migrate in host embryos. Pharmacological inhibition of PTP4A3 on dissected neural crest cells significantly reduced their migration velocity in vitro. Our results demonstrate that PTP4A3 is required for cephalic neural crest migration in vivo during embryonic development.
???displayArticle.pubmedLink???
24376839
???displayArticle.pmcLink???PMC3871671 ???displayArticle.link???PLoS One
Figure 1. Spatial expression profile of xlPTP4A3 during embryogenesis.
A-K) Whole-mount in situ hybridization showing the spatial expression of xlPTP4A3 during early Xenopus development. A'-K') Corresponding negative control using a sense probe of xlPTP4A3 mRNA. L) Whole-mount in situ hybridization of xlPTP4A3 in NC explants dissected at stage 17. L') Corresponding negative control using a sense probe of xlPTP4A3 mRNA. M) Whole-mount in situ hybridization of the NC marker xlSNAI2 on stage 17-dissected NC explants. s1-s3) Transverse sections through a stage 25 embryo stained by whole-mount in situ hybridization for xlPTP4A3 mRNA. Sense) Corresponding negative control using an xlPTP4A3 mRNA sense probe. sc: spinal cord, nc: notochord, ov: otic vesicle, ac: archenteron.
doi:10.1371/journal.pone.0084717.g001
Figure 2. Depletion of xlPTP4A3 reduces NCC territory.
Control 5MM-MO or xlPTP4A3-MO were injected at the four-cell stage in the animal pole region and embryos were cultured until stage 22. A) Morpholino sequence targeting xlPTP4A3. B) xlPTP4A3-MO specifically knocked down the translation of xlPTP4A3 in vitro using the TNT® Coupled Reticulocyte Lysate System. C) xlPTP4A3 depleted embryos showed blockade of NCC territory (a-a') and can be rescued by co-injection of mouse mPTP4A3 (c-c'), as shown by whole-mount in situ hybridization on xlTWIST. The injected side was monitored using the co-injection of nuclear-targeted β-galactosidase (red dotted signal). Injection of the control 5MM-MO does not affect the NCCs territory, as in the control noninjected embryos (b-b'). D) Quantitative results of relative phenotype (**p<0,01). E) The phenotype quantification was determined as the length of the NC migratory streams showing that the migratory streams are shorter in the injected side than in the uninjected side (n=15) (***p<0,001). F) Immunodetection of cleaved caspase 3 on xlPTP4A3-MO injected embryos. Two phenotypes are observed: one of weaker apoptosis in the injected side compared to the uninjected side (a-a') and one of no differential apoptosis between the two sides (b-b').
doi:10.1371/journal.pone.0084717.g002
Figure 3. xlPTP4A3 gain of function induces strengthening of the anterior NC migration streams in vivo.
xlPTP4A3, mmPTP4A3 or the mutant form mmPTP4A3(C104S) were injected at the four-cell stage in the animal pole region, and embryos were cultured until stage 22. A) Overexpression of xlPTP4A3 induces a strengthening (b, d vs. d') and/or lengthening (a, c) of the anterior NC migration streams as showed by whole-mount in situ hybridization on xlTWIST. B) xlPTP4A3 corresponding phenotype quantification was determined as the area of the NC migratory streams showing that the migratory streams surface is greater in the injected side than in the uninjected side (n=15) (**p<0,01). C) Overexpression of mmPTP4A3 causes a strengthening and/or lengthening (e vs.e', f) of the anterior NC migration streams while overexpression the mutant form mmPTP4A3(C104S) does not seem to significantly affect the migration of the NC (g vs.g', h). D) mmPTP4A3 or mmPTP4A3(C104S) corresponding phenotype quantification was determined as the area of the NC migratory streams showing that mmPTP4A3 injected embryos display a greater anterior NC area in the injected side than in the uninjected side while no difference in the anterior NC area could be observed in the mmPTP4A3(C104S) injected embryos between the two sides (n=15) (**p<0,01). E) Immunodetection of phosphoHistone 3 (Ser10) on xlPTP4A3 gain of function injected embryos. Injection of xlPTP4A3 does not seem to affect cell proliferation in the injected side relative to that of the uninjected side (a vs.b).
doi:10.1371/journal.pone.0084717.g003
Figure 4. Depletion of xlPTP4A3 inhibits both migration of NCC and uveal melanoma cells.
A) Isotopic and isochronic grafts of xlPTP4A3-depleted NC explants into host embryos showed a delayed NCC migration (b-b') when compared to the control histone 2b-GFP NC explants (a-a'). B) Timelapse videomicroscopy of stage 17-derived NCC treated with a pharmacological inhibitor of PTP4A3, a rhodanine derivative (PRL-3 inhibitor I), shows that inhibition of PTP4A3 increases the average of pausing NC cells and strongly decreases the migration velocity of the treated cells (relative to that of vehicle treated cells). The result is representative of three independent experiments and the average of counted cells is 60 cells per condition (***p<0,001). C) Timelapse videomicroscopy of uveal melanoma OCM1 cells stably expressing EGFP-PTP4A3, EGFP-PTP4A3(C104S) or EGFP on collagen I shows that inhibition of PTP4A3, using PRL-3 Inhibitor I, decreases specifically the migration velocity of the PTP4A3 expressing cells (relative to the velocity of untreated and control cells). The result is representative of three independent experiments and the average of counted cells is 50 cells per condition (***p<0,001).
doi:10.1371/journal.pone.0084717.g004
ptp4a3 (protein tyrosine phosphatase type IVA, member 3) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 9, animal view (left) and vegetal (right).
ptp4a3 (protein tyrosine phosphatase type IVA, member 3) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 25, lateral view, anteriorleft, dorsal up.
ptp4a3 (protein tyrosine phosphatase type IVA, member 3) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 34, lateral view, anteriorleft, dorsal up.
Aceto,
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.
2012, Pubmed
Aceto,
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop.
2012,
Pubmed
Basak,
The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.
2008,
Pubmed
Couly,
Interactions between Hox-negative cephalic neural crest cells and the foregut endoderm in patterning the facial skeleton in the vertebrate head.
2002,
Pubmed
Diener-West,
A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.
1992,
Pubmed
Egan,
Epidemiologic aspects of uveal melanoma.
1988,
Pubmed
Grammer,
Use of large-scale expression cloning screens in the Xenopus laevis tadpole to identify gene function.
2000,
Pubmed
,
Xenbase
Harland,
Xenopus research: metamorphosed by genetics and genomics.
2011,
Pubmed
,
Xenbase
Hopwood,
A Xenopus mRNA related to Drosophila twist is expressed in response to induction in the mesoderm and the neural crest.
1989,
Pubmed
,
Xenbase
Laurent,
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.
2011,
Pubmed
Lian,
Effect of protein-tyrosine phosphatase 4A3 by small interfering RNA on the proliferation of lung cancer.
2012,
Pubmed
Liang,
PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
2007,
Pubmed
Lin,
Expression of phosphatase of regenerating liver family genes during embryogenesis: an evolutionary developmental analysis among Drosophila, amphioxus, and zebrafish.
2013,
Pubmed
Matter,
Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.
2001,
Pubmed
Monsoro-Burq,
Neural crest induction by paraxial mesoderm in Xenopus embryos requires FGF signals.
2003,
Pubmed
,
Xenbase
Monsoro-Burq,
A rapid protocol for whole-mount in situ hybridization on Xenopus embryos.
2007,
Pubmed
,
Xenbase
Nakamura,
Protein tyrosine phosphatase activity in the neural crest is essential for normal heart and skull development.
2009,
Pubmed
Onken,
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.
2010,
Pubmed
Park,
Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening.
2008,
Pubmed
Peng,
PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.
2009,
Pubmed
Sater,
Induction of neuronal differentiation by planar signals in Xenopus embryos.
1993,
Pubmed
,
Xenbase
Sauka-Spengler,
Evolution of the neural crest viewed from a gene regulatory perspective.
2008,
Pubmed
Stephens,
PRL phosphatases as potential molecular targets in cancer.
2005,
Pubmed
Thiery,
Epithelial-mesenchymal transitions in development and disease.
2009,
Pubmed
Tsien,
The green fluorescent protein.
1998,
Pubmed
Wang,
PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
2007,
Pubmed
Yang,
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
2004,
Pubmed
Zheng,
Snail as a key regulator of PRL-3 gene in colorectal cancer.
2011,
Pubmed
Zimmerman,
Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer.
2013,
Pubmed
